Dr. Wei-Qin Zhao

Dr. Wei-Qin Zhao

Scientific Review Officer



Biography

Division:
Division of Neuroscience, Development and Aging DNDA
IRG:
Brain Disorders and Clinical Neuroscience BDCN
Study Section:
Clinical Neuroimmunology and Brain Tumors CNBT

Dr. Wei-Qin Zhao is the Scientific Review Officer for CSR’s Clinical Neuroimmunology and Brain Tumors (CNBT) study section.

She received her medical training from Sun Yat-sen University of Medical Sciences in China, and a Ph.D. in neurobiology from LaTrobe University in Australia. She worked as a postdoctoral fellow in LaTrobe University, a lecturer in Monash University, Australia, and a Visiting Fellow in National Institute of Neurological Disorders and Stroke, NIH. She then took a position of associate professor in Blanchette Rockefeller Neurosciences Institute, followed by a Visiting Scholar in Northwestern University. Prior to joining CSR in 2011, she was a senior research biologist at Merck Research Laboratories. Dr Zhao’s research interests are in molecular/cellular mechanisms underlying learning and memory, and drug discovery for cognitive disorders such as Alzheimer’s disease and schizophrenia.